Saptalis Pharmaceuticals, LLC – Trademark Portfolio

Entity Type: 16

Saptalis Pharmaceuticals, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include LIKMEZ and SAPTALIS. The owner is based in Hauppauge, NY.

45 Davids Drive

Hauppauge, NY 11788

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ELZETO
ELZETO
Pending 2026
OVESLI
OVESLI
Pending 2026
LIKMEZ
LIKMEZ
Registered 2022
SAPTANA
SAPTANA
Abandoned 2022
SAPTANA
SAPTANA
Abandoned 2018
SAPTALIS
SAPTALIS
Registered 2016

Trademark Classifications

Saptalis Pharmaceuticals, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Saptalis Pharmaceuticals, LLC have?

Saptalis Pharmaceuticals, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 2 abandoned.

What trademark classes does Saptalis Pharmaceuticals, LLC file in?

Saptalis Pharmaceuticals, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Saptalis Pharmaceuticals, LLC's most well-known trademarks?

Saptalis Pharmaceuticals, LLC's registered trademark portfolio includes well-known marks such as LIKMEZ and SAPTALIS. These are among 2 currently registered trademarks in the portfolio.

What is Saptalis Pharmaceuticals, LLC's trademark registration success rate?

Saptalis Pharmaceuticals, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.